What’s emerged so far is a crowded, fragmented market of space domain awareness (SDA) platforms built on different sensors, catalogs and analytics. The result: overlapping data streams and ...
Discover Elutia's Q3 2025 strategy: strong cash position, focus on breast reconstruction tech, and clear product launch roadmap.
1don MSN
10x Genomics signals 5% sequential revenue growth for Q4 2025 as new product launches drive adoption
Discover key Q3 2025 earnings insights for 10x Genomics (TXG): revenue growth, new product launches, and Q4 outlook.
The firm's data and services revenues grew 26 percent to $81.3 million, while genomics revenues more than doubled to $252.9 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback